RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that results of 32 investigator-initiated and Company-sponsored trials related to the Company’s products will be presented at the 71st American College of Gastroenterology Annual Scientific Meeting, beginning Sunday, October 22, 2006.
